NCT02555982 - Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

September 17, 2021

Study Completion Date

September 1, 2022

Conditions

Essential Head Tremor

Interventions

DRUG

BOTOX ® 200 Unités

"Patients eligible for inclusion will be randomized to one of the two groups:~* Experimental group: 60 patients will receive 2 injections of Btx A (BOTOX - Allergan), one on D0 and one at 12W (into each splenius capitis).~* Control group: 60 patients will receive 2 injections of placebo, one on D0 and one at 12W (into each splenius capitis)."

DRUG

Placebo

Control group: 60 patients will receive 2 injections of placebo, one on D0 and one at 12W (into each splenius capitis).

Trial Locations (17)

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

Unknown

Centre Hospitalier Pays D'Aix, Aix-en-Provence

CHU d'Amiens, Amiens

Hôpital Jean Minjoz, Besançon

Hôpital Haut-Levêque, Bordeaux

Hôpital R Salendro, Lille

Hôpital neurologique, Lyon

Hôpital de la Timone, Marseille

CH Narbonne, Narbonne

Hôpital Caremeau, Nîmes

AP-HP, Paris

Fondation Rothschild, Paris

Hopital Lariboisière, Paris

Hôptal Avicenne de Bobigny, Paris

CHU de Poitiers, Poitiers

Hôpital de Hautepierre, Strasbourg

CHU de Toulouse, Toulouse